IP & Innovation Intelligence
Connect Scientific, Technology, IP, and Safety Intelligence to Advance Innovation With Confidence.
Evalueserve combines scientific and technical expertise, innovation research, patent intelligence, toxicology, Data and AI, and managed execution to help organizations identify opportunities, assess technologies, develop safer products, and make stronger R&D decisions.
Our Point of View
Innovation Slows When Evidence, Opportunity, and Risk Are Evaluated Separately.
Scientific literature, patents, emerging technologies, startups, regulations, product data, safety evidence, and market needs often sit across different teams and systems.
R&D teams may identify a promising technology without understanding the intellectual-property landscape. Innovation teams may identify a partner without validating technical readiness. Product teams may progress a formulation before the toxicological evidence and regulatory implications are fully understood.
AI can accelerate discovery and analysis, but it cannot determine scientific relevance, technical feasibility, safety, or strategic fit without domain expertise and transparent evidence.
The opportunity is to connect research, innovation, IP, toxicology, and regulatory intelligence within the decisions that move an idea toward a viable product.
The Decisions We Improve
Focused Expertise Across the Decisions That Move Innovation Forward.
Research & Evidence Discovery
Find, structure, and interpret relevant scientific, technical, patent, regulatory, and market evidence across large and rapidly changing information environments.
Innovation & Technology Scouting
Identify and evaluate technologies, materials, ingredients, startups, partners, and research organizations against defined technical and commercial requirements.
R&D Strategy & Portfolio Prioritization
Combine technical maturity, market potential, strategic fit, feasibility, risk, competition, and investment requirements to prioritize R&D opportunities.
IP Landscape & Freedom to Operate
Assess patents, ownership, claims, whitespace, infringement risk, competitive positioning, and freedom to operate before resources are committed.
Toxicology & Product Safety
Evaluate hazards, exposure, ingredients, materials, formulations, products, and available scientific evidence to support safe product development and regulatory compliance.
Partner, Licensing & Commercialization Strategy
Identify potential partners, assess capabilities, evaluate licensing opportunities, and connect technical innovation with market and commercial pathways.
The Connected Workflow
From an Innovation Question to a Viable, Defensible and Safer Product Pathway.
Define the Innovation Need
Clarify the customer need, technical problem, product requirement, research question, or strategic opportunity that the organization is trying to address.
Key InputsDiscover the Evidence
Search scientific literature, patents, standards, regulatory sources, products, technologies, startups, and other relevant information.
Key InputsStructure the Landscape
Classify technologies, materials, ingredients, companies, claims, mechanisms, applications, risks, and relationships around the innovation question.
Key InputsAssess Feasibility and Differentiation
Evaluate technical maturity, performance, scalability, strategic fit, competitive position, IP constraints, and potential development pathways.
Key InputsEvaluate Safety and Regulatory Risk
Assess toxicological evidence, hazards, exposure, product use, ingredients, formulations, regulatory requirements, and evidence gaps.
Key InputsPrioritize the Pathway
Compare internal development, external partnering, licensing, acquisition, reformulation, and alternative technical routes.
Key InputsMonitor and Improve
Track new science, patents, regulations, competitors, safety evidence, and technology progress as the innovation moves forward.
Key InputsClient Impact
Proven Results at Scale.
Evidence that connected IP and innovation intelligence improves outcomes.
- Swipe to See More
Insights
A Deeper View of Scientific, Innovation and Safety Decisions.
Beyond the Answer: Why Expertise Still Matters in the Age of AI
As AI transforms how research is conducted, organizations must balance automation with human expertise. Professional judgment remains critical for interpreting evidence, managing uncertainty, and ensuring sound decision-making.
Evalueserve CEO Pallab Deb on AI Adoption: Turning AI Pilots into Enterprise Value
Evalueserve CEO Pallab Deb explains why most AI initiatives fail to scale and how domain expertise, technology, and trusted partnerships help organizations turn AI investments into measurable business value.
The ROI of Gen AI
A practical roadmap to value creation. Learn how leading enterprises are turning Generative AI into measurable revenue growth and ROI.
The Ultimate Guide to Domain-Specific AI
Domain-specific AI is the ideal solution for businesses, enabling them to process and analyze data within a specific industry and function.
- Swipe to See More
IP & Innovation Intelligence Expertise
Meet Our Domain Experts.
Meet the scientists, engineers, toxicologists, patent researchers, innovation strategists, and Data and AI specialists who connect evidence, technology, safety, and intellectual property to improve R&D decisions.
Frequently Asked Questions
IP & Innovation Intelligence Capabilities.
Evalueserve uses Data and AI to search, collect, classify, connect, and analyze scientific literature, patents, product information, regulatory data, technology signals, company information, and safety evidence.
AI agents can support literature screening, evidence extraction, patent classification, technology monitoring, company profiling, data summarization, and initial comparison of alternatives.
Knowledge graphs and ontologies can connect technologies, ingredients, materials, patents, products, companies, risks, and applications.
Scientists, engineers, patent professionals, and toxicologists define relevance, technical criteria, evidence standards, limitations, exceptions, and validation requirements so that AI accelerates the work without replacing scientific judgment.
R&D research typically focuses on answering a defined scientific or technical question.
Research & Innovation Intelligence connects that research with technology scouting, patent intelligence, toxicology, regulatory evidence, market need, partner assessment, and strategic prioritization.
The objective is not simply to collect information. It is to help the organization determine which innovation pathways are technically viable, differentiated, safe, protectable, and commercially relevant.
AI can accelerate literature mining, evidence extraction, data structuring, study summarization, initial endpoint mapping, and the preparation of draft assessment components.
It can also help toxicologists navigate larger evidence bases and identify information that may require closer review.
However, toxicological conclusions depend on study quality, exposure context, biological relevance, uncertainty, conflicting evidence, regulatory expectations, and expert interpretation.
AI outputs therefore require transparent sources, confidence indicators, validation rules, documented limitations, and review by qualified toxicologists. AI should support scientific judgment rather than act as the final decision-maker.
Evalueserve supports patent searching, prior-art research, patentability, invalidity, freedom to operate, landscaping, competitive intelligence, portfolio analysis, technology monitoring, and licensing.
The work combines patent databases, non-patent literature, product information, scientific knowledge, technical expertise, and legal research requirements.
AI can accelerate searching, classification, clustering, evidence identification, and monitoring. Patent and technical specialists validate relevance, interpret claims, identify limitations, and prepare defensible analysis.